Skip to main content

Table 6 Previous reports of PEM-induced ILD and our cases

From: Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease

Ā 

A/G

Before PEM CT findings

Histology

Post RTx

Pre Chemotherapy

Combination therapy

No. of cycle

Treatment

Outcome

Reference

1

65/M

UIP

MPM

No

None

CBDCA

1

Steroid Pulse

Dead

[17] S Sakamoto et al

2

66/F

None

NSCLC (Ad)

No

CDDP + VNR

CDDP

4

Steroid (oral)

Recover

[19] HO Kim. et al

3

71/M

None

MPM

No

None

CDDP

1

Steroid Pulse

Dead

[18] K Nagata. et al

4

77/M

None

MPM

No

None

CBDCA

1

Steroid Pulse

Dead

[18] K Nagata. et al

5

72/F

None

NSCLC (Ad)

No

CBDCA + PEM

CBDCA

2

Steroid (oral)

Recover

[20] B Dhakal. et al

6

64/M

RTx-P

NSCLC (Ad)

Yes

CBDCA + VP-16

None

2

Steroid Pulse

Dead

[21] A Hochstrasser. et al

7

51/M

RTx-P

NSCLC (Ad)

Yes

CDDP + DTX

None

2

Steroid Pulse

Recover

[21] A Hochstrasser. et al. 2012

8

69/M

None

NSCLC (Ad)

No

CBDCA + GEM

None

1

Steroid Pulse

Recover

[22] KH Kim et al

1

64/M

UIP

NSCLC (Ad)

No

CBDCA + PTX + BEV

None

2

Steroid Pulse

Dead

Our case

2

71/M

UIP

NSCLC (Ad)

No

None

None

1

Steroid Pulse

Recover

Our case

3

68/M

GGO

NSCLC (Ad)

No

CBDCA + PTX

None

2

Steroid Pulse

Dead

Our case

4

67/F

None

NSCLC (Ad)

No

CBDCA + PTX, DTX, Gefitinib,

None

3

Drug withdrawn

Recover

Our case

  1. PEM: Pemetrexed, A/G: Age/Gender, UIP: Usual Interstitial Pneumonitis, GGO: Groud Grass Opacity, NSCLC: Non Small Cell Lung Cancer, Ad: Adenocarcinoma, PS: performance Status, RTx: Radiation Therapy, RTX-p: radiation pneumonitis, VNR: Vinorelbine, CBDCA: Calboplatin, PTX: Paclitaxel, BEV: Bevacizmab,VP-16: Etoposide, DTX: Docetaxel, GEM: Gemcitabine, UK: Unknown, MPM: Malignancy Pleural Mesotelioma.